{"data":{"name":"com.midgardfinance/drugs","title":"Midgard Finance drug data","description":"Obesity and incretin drug trials: weight loss by dose with its estimand, adverse events, catalysts","version":"0.1.2","websiteUrl":"https://www.midgardfinance.com/obesity/","repositoryUrl":null,"remotes":[{"type":"streamable-http","url":"https://mcp.midgardfinance.com/mcp"}],"packages":[],"status":"active","isLatest":true,"publishedAt":"2026-10-30T09:21:33.279Z","updatedAt":"2026-10-30T09:21:33.279Z","source":"official-registry","verification":"official","confidence":100,"stars":null,"sources":[{"source":"official-registry","sourceId":"com.midgardfinance/drugs","verification":"official","confidence":100,"stars":null,"updatedAt":"2026-10-30T09:21:33.279Z","title":"Midgard Finance drug data","description":"Obesity and incretin drug trials: weight loss by dose with its estimand, adverse events, catalysts","websiteUrl":"https://www.midgardfinance.com/obesity/","repositoryUrl":null}],"toolIndex":{"tools":[{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"compare_efficacy","title":"Compare weight-loss efficacy","description":"The extracted weight-loss table for the named drugs, joined to trial design, one row per arm and timepoint.\n\nRows are NOT collapsed to one number per drug. The corpus holds several doses, timepoints and\nestimands per trial, and picking a single winner per drug would mean choosing between them\nhere, silently and on the caller's behalf. The comparison is theirs to make; this returns the\nrows and the labels needed to make it correctly.\n","inputSchema":{"type":"object","properties":{"drugs":{"items":{"type":"string"},"title":"Drugs","type":"array"},"timepoint_weeks":{"anyOf":[{"type":"integer"},{"type":"null"}],"default":null,"title":"Timepoint Weeks"},"estimand":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Estimand"},"metric":{"default":"mean_weight_change_pct","title":"Metric","type":"string"},"limit":{"default":10,"title":"Limit","type":"integer"}},"required":["drugs"],"title":"compare_efficacyArguments"},"annotations":{"title":"Compare weight-loss efficacy","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"590be56a3df5c76f72cb3afba3fd4995e042ac5a93ddcdba712f6956348ced20","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"get_adverse_events","title":"Get adverse event rates","description":"Extracted adverse-event rates for a named drug or trial, by arm, with the arithmetic that was checked.\n\n`drug` is a molecule or a brand (tirzepatide or Zepbound). `ae_type` narrows to a kind of event,\nevery word of it found in the stored type: discontinuation_ae is the share who stopped the drug\nbecause of an adverse event (quit over side effects), and the others include\ndiscontinuation_ae_gi, nausea, vomiting, diarrhea, constipation, serious_ae, any_ae and death.\n`available_ae_types` lists the types the named drug or trial holds. `not_published` names the\nmatching trials that hold no rows because their side-effect figures were never published, with\nwhat the sponsor did say (REDEFINE 4, the CagriSema and tirzepatide head-to-head).\n\n`verification` is carried through verbatim. It is the raw-count recomputation recorded when the\nrow was extracted (\"997/2481 active = 40.18%\"), and it is what lets a caller see that the\npercentage was checked against the paper rather than copied from an abstract.\n","inputSchema":{"type":"object","properties":{"drug":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Drug"},"trial":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Trial"},"ae_type":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Ae Type"},"limit":{"default":10,"title":"Limit","type":"integer"}},"title":"get_adverse_eventsArguments"},"annotations":{"title":"Get adverse event rates","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"faac5360fd65c93904a9d5e478485fba8d7b6166d16b8487ee005a3d0d0732b3","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"get_drug","title":"Get drug record","description":"Full record for one drug, with its efficacy figures estimand-tagged and its page URL.\n\nMatching goes slug, then exact name or brand, then substring, so \"wegovy\", \"Wegovy HD\" and\n\"semaglutide-obesity\" all land somewhere sensible without the caller knowing the slug scheme.\n","inputSchema":{"type":"object","properties":{"name":{"title":"Name","type":"string"}},"required":["name"],"title":"get_drugArguments"},"annotations":{"title":"Get drug record","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"7bdd7be5288d3989aeb6f6579a5d3c26806b4dbb5228b775d14299ebbc0a5708","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"get_trajectory","title":"Get weight-loss trajectory","description":"The digitised weight-loss curve for a drug: week-by-week points, plus per-dose series.\n\nReturned with `endpoint_pct` and its estimand alongside the curve, because the endpoint marker\nand the last plotted point are different quantities and the curve alone does not say which one\na reader is looking at.\n","inputSchema":{"type":"object","properties":{"drug":{"title":"Drug","type":"string"}},"required":["drug"],"title":"get_trajectoryArguments"},"annotations":{"title":"Get weight-loss trajectory","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"c743b338b47563a91ba82858f766c34b07c370c620dc5c4d516f657699d6bd49","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"get_trial","title":"Get trial design","description":"One trial's design, by NCT number or by trial key (SURMOUNT-1, scale, redefine-1).","inputSchema":{"type":"object","properties":{"identifier":{"title":"Identifier","type":"string"}},"required":["identifier"],"title":"get_trialArguments"},"annotations":{"title":"Get trial design","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"5322a598ab148d9ccf0ee2fd937ba6717ba15cb7924be43dd6a6065091a3e1dc","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"list_catalysts","title":"List upcoming catalysts","description":"Upcoming and recent readouts, approvals and trial starts across sponsors, oldest first.\n\nFor what comes next, pass from_date as today and pending_only=true, and kind=\"readout\" for trial results;\nan event whose outcome is set has already happened.\n\nfrom_date and to_date take YYYY-MM-DD, YYYY-MM, YYYY-Qn or YYYY. An event is dated as precisely as its sponsor\nguided it (a day, a month, a quarter or a year), and it is kept when that period overlaps the window, so an event\nguided to 2026-Q4 is still listed from 2026-11-10.\n\narea: \"obesity\" or \"diabetes\". kind: \"readout\" (trial results, including cardiovascular outcomes trials),\n\"regulatory\" (submissions, decisions, coverage and launches), \"trial_start\" or \"company\" (earnings, conferences,\ninvestor days). pending_only: only events with no outcome recorded yet.\n","inputSchema":{"type":"object","properties":{"from_date":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"From Date"},"to_date":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"To Date"},"tier":{"anyOf":[{"type":"integer"},{"type":"null"}],"default":null,"title":"Tier"},"area":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Area"},"kind":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Kind"},"pending_only":{"default":false,"title":"Pending Only","type":"boolean"},"limit":{"default":10,"title":"Limit","type":"integer"}},"title":"list_catalystsArguments"},"annotations":{"title":"List upcoming catalysts","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"39e6b6aef5dfee3c2a0d10aa739a2e75ed23dd6d5868e469765a5e90768bddb9","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"list_news","title":"List latest news","description":"The latest news the site's hubs print, newest first, with date, headline, source and page.\n\nUse it for \"what is new\" and \"latest announcement\" questions. It holds the eight newest items\nof each hub: obesity, Novo Nordisk and Eli Lilly. `company` matches the hub (Novo Nordisk,\nEli Lilly) or the drug's sponsor, `drug` a drug or brand in the item or its headline, `query`\na word in the headline (MASH, approval). `kind` on a Novo hub item says what it is (clinical,\nregulatory, corporate, results, competitor: a rival's event that bears on Novo). An event older\nthan a hub's eight newest is not here: say so rather than guess. A headline's efficacy figure is\non the estimand the headline names, if any, and is not comparable with one on another.\n","inputSchema":{"type":"object","properties":{"company":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Company"},"drug":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Drug"},"query":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Query"},"limit":{"default":10,"title":"Limit","type":"integer"}},"title":"list_newsArguments"},"annotations":{"title":"List latest news","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"418f7096b96efee4d79bca250986c7df324e4aed8f71e42a0f317b8accb4dd03","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"},{"serverName":"com.midgardfinance/drugs","endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","name":"search_drugs","title":"Search drugs","description":"Search the drug boards by free text and by field.\n\n`query` also matches the other indications a molecule is pursuing, from the indications matrix\n(MASH, CKD, sleep apnea, heart failure, CV outcomes, type 2 diabetes, and their trial names),\nso \"MASH\" finds every cardiometabolic drug with a MASH programme and its status. `sponsor`\nalso matches a partner the matrix names (survodutide is licensed from Zealand Pharma to\nBoehringer Ingelheim). Each result carries its `indications` row, or null for a drug the\nmatrix does not cover (cancer and immunology drugs, and MASH-only drugs, are not in it).\n","inputSchema":{"type":"object","properties":{"query":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Query"},"area":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Area"},"sponsor":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Sponsor"},"status":{"anyOf":[{"type":"string"},{"type":"null"}],"default":null,"title":"Status"},"limit":{"default":10,"title":"Limit","type":"integer"}},"title":"search_drugsArguments"},"annotations":{"title":"Search drugs","readOnlyHint":true,"destructiveHint":false,"openWorldHint":false},"definitionHash":"a51e24560112902af388c765900d1cd74945ba0fae93ecb940b4f8eadffd9d5a","schemaStatus":"valid","origin":"official-registry","observedAt":"2026-11-16T16:47:00.506Z","metadataTrust":"untrusted"}],"endpoints":[{"endpointFingerprint":"7861d2ef8342e46d8743df51dab2545857ddb68f6d4fb6edc87d7bb13a0e422e","protocol":"streamable-http","status":"indexed","toolCount":8,"observedAt":"2026-11-16T16:47:00.506Z"}],"authentication":"unknown"},"connectionConfigurations":{"status":"ready","authentication":"not embedded","clients":{"Claude Desktop":{"mcpServers":{"com.midgardfinance/drugs":{"url":"https://mcp.midgardfinance.com/mcp"}}},"Cursor":{"mcpServers":{"com.midgardfinance/drugs":{"url":"https://mcp.midgardfinance.com/mcp"}}},"VS Code":{"servers":{"com.midgardfinance/drugs":{"type":"http","url":"https://mcp.midgardfinance.com/mcp"}}}}},"resourceType":"mcp-server","callable":true,"runtime":{"callable":true,"protocols":["mcp"]},"interfaces":[{"protocol":"mcp","transport":"streamable-http","url":"https://mcp.midgardfinance.com/mcp"}],"profile":{"apiVersion":"1","schemaVersion":"1","id":"mcp-server:com.midgardfinance%2Fdrugs","resourceType":"mcp-server","canonicalUrl":"https://www.agentsjunction.com/api/v1/servers/com.midgardfinance%2Fdrugs","name":"com.midgardfinance/drugs","description":"Obesity and incretin drug trials: weight loss by dose with its estimand, adverse events, catalysts","interfaces":[{"protocol":"mcp","transport":"streamable-http","url":"https://mcp.midgardfinance.com/mcp"}],"capabilities":[],"identity":{"source":"official-registry","websiteUrl":"https://www.midgardfinance.com/obesity/","repositoryUrl":null,"version":"0.1.2"},"verification":{"state":"official","confidence":100},"operations":{"resourceType":"mcp-server","name":"com.midgardfinance/drugs","status":"online","lastCheckedAt":"2026-11-20T05:17:26.874Z","lastSuccessfulCheck":"2026-11-20T05:17:26.874Z","latencyMs":328,"consecutiveFailures":0,"isStale":false,"checks":{"endpointReachable":true,"protocolValid":true,"agentCardValid":null,"mcpHandshakeValid":true},"lastSeen":null,"lastSuccessfulInteraction":null,"lastHealthCheck":"2026-11-20T05:17:26.874Z","source":{"type":"health-check","url":null},"observedAt":"2026-11-20T05:17:26.874Z"},"security":null,"timestamps":{"createdAt":"2026-10-30T09:21:33.279Z","updatedAt":"2026-10-30T09:21:33.279Z","observedAt":"2026-11-20T05:17:26.874Z"},"compatibility":{"serverVersion":"0.1.2","protocolVersions":[{"protocol":"mcp","version":null}]}}}}